Maksymilian Swiniarski has been appointed the new chairman of the board of directors of TZF Polfa S.A. The decision to appoint Maksymilian Swiniarski to this position was made by the Company's Supervisory Board after a qualification procedure, for which 19 candidates and candidates applied. The new president will replace Jaroslaw Król, who headed the Company since June 2017.
Maksymilian Swiniarski is a leader with extensive experience in business and project management. For more than 20 years he has been associated with the pharmaceutical industry - he worked in the largest biotechnology corporations in the world, where he held key positions and gained the knowledge and skills necessary to manage a dynamically growing company such as TZF Polfa. In the structures of such companies as BAYER, Eli Lilly Poland, AstraZeneca and Synthaverse, he was responsible for drug launches and successfully implemented the strategy for the development...
Content locked
To gain access to the complete English section of the Medexpress.pl, kindly reach out to us at [email protected].
If you already have an account, please log in
